Search - tctmd.com

Displaying 1 - 20 of 26

Sort: Relevancy | Date

News Conference News TCT 2025

STRIVE: Low-Dose Alteplase Ineffective in STEMI Patients With Large Thrombus

Michael O'Riordan

October 28, 2025

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

News Conference News TCT 2024

CONFIRM2 Shows Power of AI-QCT to Use Plaque Features to Predict CAD Events

Yael L. Maxwell

November 01, 2024

News Conference News TCT 2024

QFR No Match for FFR in Guiding Revascularizations: FAVOR III Europe

Caitlin E. Cox

October 30, 2024

News Conference News TCT 2023

No Mortality Signal for iFR in Real-world Use: SWEDEHEART

Caitlin E. Cox

October 26, 2023

News Conference News TCT 2022

Calcified Nodules Signal Worst Outcome Among OCT-Defined ACS Causes

Todd Neale

September 22, 2022

News Conference News TCT 2022

CCTA in Patients With Prior CABG Cuts Complications of Invasive Angio: BYPASS-CTCA

Yael L. Maxwell

September 21, 2022

News Conference News TCT 2021

iFR Matches FFR Through 5 Years: iFR-SWEDEHEART

Caitlin E. Cox

November 04, 2021

News Conference News TCT 2021

OCT Guidance Cuts Stent Use in STEMI Without Plaque Rupture: EROSION III

Shelley Wood

November 04, 2021

News Conference News TCT 2021

Good Long-term Results With FANTOM BVS, but More Data Needed

Michael O'Riordan

October 21, 2021

News Conference News TCT 2021

No Harm From Thrombolytics in SCAD Patients With STEMI

Michael O'Riordan

October 13, 2021

News Conference News TCT 2020

FFR Insights Before and After PCI: Fresh Food for Thought

Caitlin E. Cox

October 16, 2020

News Conference News TCT 2020

DISRUPT CAD III: Lithotripsy Boosts Stent Expansion in Highly Calcified Lesions

L.A. McKeown

October 15, 2020

News Conference News TCT 2020

Prophylactic PCI of Vulnerable Plaques? PROSPECT II/ABSORB

Michael O'Riordan

October 14, 2020

Presentation TCT 2020

PROSPECT II: A Prospective Natural History Study Using NIRS-IVUS Imaging in Patients with Acute Myocardial Infarction

Presenter: David Erlinge

October 14, 2020

News Opinion Off Script TCT 2019

Off Script: PCI of the Future? Let’s Break Down the Border Between Physiology and Anatomy

Kwan S. Lee

October 14, 2019

News Conference News TCT 2019

IVUS-XPL at 5 Years Shows Durability of Imaging Guidance in PCI

Caitlin E. Cox

October 08, 2019

News Conference News TCT 2019

FORZA: For Intermediate Lesions, OCT-Guided PCI Costs More, Yields Better Outcomes vs FFR

Caitlin E. Cox

October 01, 2019

News Conference News TCT 2018

Next Steps With NIRS: Lipid-Rich Plaque Study Shows Promise Identifying High-Risk Patients, Plaques

Yael L. Maxwell

September 24, 2018

News Conference News TCT 2017

FAME 2 at 3 Years: Outcomes, Symptoms Better With PCI vs OMT in Stable CAD, at Similar Cost

L.A. McKeown

November 02, 2017

Advertisement

STRIVE: Low-Dose Alteplase Ineffective in STEMI Patients With Large Thrombus

What’s Going to Be Hot at TCT 2025

CONFIRM2 Shows Power of AI-QCT to Use Plaque Features to Predict CAD Events

QFR No Match for FFR in Guiding Revascularizations: FAVOR III Europe

No Mortality Signal for iFR in Real-world Use: SWEDEHEART

Calcified Nodules Signal Worst Outcome Among OCT-Defined ACS Causes

CCTA in Patients With Prior CABG Cuts Complications of Invasive Angio: BYPASS-CTCA

iFR Matches FFR Through 5 Years: iFR-SWEDEHEART

OCT Guidance Cuts Stent Use in STEMI Without Plaque Rupture: EROSION III

Good Long-term Results With FANTOM BVS, but More Data Needed

No Harm From Thrombolytics in SCAD Patients With STEMI

FFR Insights Before and After PCI: Fresh Food for Thought

DISRUPT CAD III: Lithotripsy Boosts Stent Expansion in Highly Calcified Lesions

Prophylactic PCI of Vulnerable Plaques? PROSPECT II/ABSORB

PROSPECT II: A Prospective Natural History Study Using NIRS-IVUS Imaging in Patients with Acute Myocardial Infarction

Off Script: PCI of the Future? Let’s Break Down the Border Between Physiology and Anatomy

IVUS-XPL at 5 Years Shows Durability of Imaging Guidance in PCI

FORZA: For Intermediate Lesions, OCT-Guided PCI Costs More, Yields Better Outcomes vs FFR

Next Steps With NIRS: Lipid-Rich Plaque Study Shows Promise Identifying High-Risk Patients, Plaques

FAME 2 at 3 Years: Outcomes, Symptoms Better With PCI vs OMT in Stable CAD, at Similar Cost

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content